Cite

HARVARD Citation

    Shah, N. et al. (n.d.). PATH-56. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA. Neuro-oncology. pp. vi170-vi171. [Online]. 
  
Back to record